packageRegadenoson

regadenoson

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Regadenoson is a cardiac drug used to help with myocardial perfusion imaging, a heart scan that shows blood flow to the heart muscle. It is an approved medicine, with one product authorised in the European Union, and is also being studied for other uses.

Summary written by glm-5.3-flash from Wikidata Q7307897 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:regadenoson
ATC codes:C01EB21
DrugBank:DB06213
PubChem CID:219024
ChEBI:135613
Wikidata:Q7307897
formula:C15H18N8O5
molar mass:390.36 g/mol (PubChem CID 219024)
logP:-1.5 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown